Florida Senate - 2022                        COMMITTEE AMENDMENT
       Bill No. SB 544
       
       
       
       
       
       
                                Ì599944WÎ599944                         
       
                              LEGISLATIVE ACTION                        
                    Senate             .             House              
                  Comm: RCS            .                                
                  01/19/2022           .                                
                                       .                                
                                       .                                
                                       .                                
       —————————————————————————————————————————————————————————————————




       —————————————————————————————————————————————————————————————————
       Appropriations Subcommittee on Health and Human Services (Boyd)
       recommended the following:
       
    1         Senate Amendment (with title amendment)
    2  
    3         Delete everything after the enacting clause
    4  and insert:
    5         Section 1. Subsections (2), (3), and (4) of section
    6  381.887, Florida Statutes, are amended to read:
    7         381.887 Emergency treatment for suspected opioid overdose.—
    8         (2) The purpose of this section is to provide for the
    9  prescribing, ordering, and dispensing prescription of emergency
   10  opioid antagonists an emergency opioid antagonist to patients
   11  and caregivers and to encourage the prescribing, ordering, and
   12  dispensing prescription of emergency opioid antagonists by
   13  authorized health care practitioners.
   14         (3)(a) An authorized health care practitioner may prescribe
   15  and dispense an emergency opioid antagonist to, and a pharmacist
   16  may order an emergency opioid antagonist with an autoinjection
   17  delivery system or intranasal application delivery system for, a
   18  patient or caregiver for use in accordance with this section.,
   19  and
   20         (b)A pharmacist pharmacists may dispense an emergency
   21  opioid antagonist pursuant to a prescription by an authorized
   22  health care practitioner. A pharmacist may dispense an emergency
   23  opioid antagonist with such a prescription or pursuant to a non
   24  patient-specific standing order for an autoinjection delivery
   25  system or intranasal application delivery system, which must be
   26  appropriately labeled with instructions for use, pursuant to a
   27  pharmacist’s order or pursuant to a nonpatient-specific standing
   28  order.
   29         (c)A such patient or caregiver is authorized to store and
   30  possess approved emergency opioid antagonists and, in an
   31  emergency situation when a physician is not immediately
   32  available, administer the emergency opioid antagonist to a
   33  person believed in good faith to be experiencing an opioid
   34  overdose, regardless of whether that person has a prescription
   35  for an emergency opioid antagonist.
   36         (4) The following persons are authorized to possess, store,
   37  and administer emergency opioid antagonists as clinically
   38  indicated and are immune from any civil liability or criminal
   39  liability as a result of administering an emergency opioid
   40  antagonist:
   41         (a) Emergency responders, including, but not limited to,
   42  law enforcement officers, paramedics, and emergency medical
   43  technicians.
   44         (b) Crime laboratory personnel for the statewide criminal
   45  analysis laboratory system as described in s. 943.32, including,
   46  but not limited to, analysts, evidence intake personnel, and
   47  their supervisors.
   48         (c)Personnel of a law enforcement agency or other agency,
   49  including, but not limited to, correctional probation officers
   50  and child protective investigators who, while acting within the
   51  scope or course of employment, come into contact with a
   52  controlled substance or persons at risk of experiencing an
   53  opioid overdose.
   54         Section 2. Paragraph (r) of subsection (2) of section
   55  381.981, Florida Statutes, is amended to read:
   56         381.981 Health awareness campaigns.—
   57         (2) The awareness campaigns shall include the provision of
   58  educational information about preventing, detecting, treating,
   59  and curing the following diseases or conditions. Additional
   60  diseases and conditions that impact the public health may be
   61  added by the board of directors of the Florida Public Health
   62  Institute, Inc.; however, each of the following diseases or
   63  conditions must be included in an awareness campaign during at
   64  least 1 month in any 24-month period:
   65         (r) Substance abuse, including, but not limited to,
   66  emergency opioid antagonists.
   67         Section 3. Subsection (8) is added to section 395.1041,
   68  Florida Statutes, to read:
   69         395.1041 Access to emergency services and care.—
   70         (8) REPORTING OF CONTROLLED SUBSTANCE OVERDOSES.—A hospital
   71  emergency room or an urgent care center that treats and releases
   72  a person in response to a suspected or actual overdose of a
   73  controlled substance must report such incident to the department
   74  if the patient was not transported by a transport service
   75  operating pursuant to part III of chapter 401. Such reports must
   76  be made using an appropriate method with secure access,
   77  including, but not limited to, the Washington/Baltimore High
   78  Intensity Drug Trafficking Overdose Detection Mapping
   79  Application Program, the Florida Prehospital EMS Tracking and
   80  Reporting System (EMSTARS), or another program identified by
   81  department rule. If a hospital emergency room or an urgent care
   82  center reports such incident, it must make its best efforts to
   83  make the report to the department within 120 hours after
   84  knowledge of the incident.
   85         Section 4. This act shall take effect July 1, 2022.
   86  
   87  ================= T I T L E  A M E N D M E N T ================
   88  And the title is amended as follows:
   89         Delete everything before the enacting clause
   90  and insert:
   91                        A bill to be entitled                      
   92         An act relating to drug-related overdose prevention;
   93         amending s. 381.887, F.S.; revising the purpose of
   94         specified provisions relating to the prescribing,
   95         ordering, and dispensing of emergency opioid
   96         antagonists to certain persons by authorized health
   97         care practitioners; authorizing pharmacists to order
   98         certain emergency opioid antagonists; providing
   99         certain authorized persons immunity from civil or
  100         criminal liability for administering emergency opioid
  101         antagonists under certain circumstances; authorizing
  102         personnel of law enforcement agencies and other
  103         agencies to administer emergency opioid antagonists
  104         under certain circumstances; amending s. 381.981,
  105         F.S.; revising requirements for a certain health
  106         awareness campaign; amending s. 395.1041, F.S.;
  107         requiring hospital emergency rooms and urgent care
  108         centers to report incidents involving a suspected or
  109         actual overdose to the department under certain
  110         circumstances; providing requirements for the report;
  111         requiring hospital emergency rooms and urgent care
  112         centers to use best efforts to report such incidents
  113         to the department within a specified timeframe;
  114         providing an effective date.